{"id": "1337061680547831811", "created_at": "2020-12-10T15:48:40.000Z", "text": "$ATNM Barron great research Rating \n\nhttps://t.co/9Pp8FOkWFD\n\n$MRK $JNJ $ABBV $SGEN $BMRN $VRTX $LLY  $AMZON $GOOGL $AZN $SNY  $GILD $ALXO $JPM  $REGN $AMGN $AZN $BIIB $JAZZ $VIR #biotech $JAZZ $VIR $NVAX $BMY $PFE $INCY $SNY $VRTX $GBT $HALO $KPTI $GLPG https://t.co/jh9b5Uw37Z", "author_id": "3435682714"}
{"id": "1336881326205628418", "created_at": "2020-12-10T03:52:00.000Z", "text": "$ABBV AbbVie Option Alert: Dec 18 $95 Calls at the Ask: 492 @ $13.85 vs 8653 OI; Earnings 2/5 Before Open [est] Ref=$108.73 [12/10/2020, 10:33:40 AM] [+$500k Sweeps Above Midpoint] Other Sweeps on: $BIDU $ING $UBER $BCOV $TPX $KGC $TAN $RMBS $LMND $HUYA $ARCC $NFLX", "author_id": "2603182496"}
{"id": "1337030704010555392", "created_at": "2020-12-10T13:45:35.000Z", "text": "$ABBV RINVOQ\u2122 (upadacitinib) Achieved Superiority Versus DUPIXENT\u00ae (dupilumab) For Primary and All Ranked Secondary Endpoints in Phase 3b Head-to-Head Study in Adults with Atopic Dermatitis", "author_id": "176597920"}
